These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26774910)

  • 61. Dry eye disease: pathophysiology, classification, and diagnosis.
    Perry HD
    Am J Manag Care; 2008 Apr; 14(3 Suppl):S79-87. PubMed ID: 18452371
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Correlation between tear film osmolarity, dry eye disease, and rheumatoid arthritis.
    Schargus M; Wolf F; Tony HP; Meyer-Ter-Vehn T; Geerling G
    Cornea; 2014 Dec; 33(12):1257-61. PubMed ID: 25255140
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Recent advances in drug treatments for dry eye disease.
    Coco G; Ambrosini G; Poletti S; Meliante LA; Taloni A; Scorcia V; Giannaccare G
    Expert Opin Pharmacother; 2023; 24(18):2059-2079. PubMed ID: 37804227
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction.
    Ramos-Llorca A; Scarpellini C; Augustyns K
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077189
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Importance of tear film instability in dry eye disease in office workers using visual display terminals: the Osaka study.
    Yokoi N; Uchino M; Uchino Y; Dogru M; Kawashima M; Komuro A; Sonomura Y; Kato H; Tsubota K; Kinoshita S
    Am J Ophthalmol; 2015 Apr; 159(4):748-54. PubMed ID: 25555800
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Therapeutic inhibitors for the treatment of dry eye syndrome.
    Rodríguez-Pomar C; Pintor J; Colligris B; Carracedo G
    Expert Opin Pharmacother; 2017 Dec; 18(17):1855-1865. PubMed ID: 29115899
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Rasch analysis of three dry eye questionnaires and correlates with objective clinical tests.
    McAlinden C; Gao R; Wang Q; Zhu S; Yang J; Yu A; Bron AJ; Huang J
    Ocul Surf; 2017 Apr; 15(2):202-210. PubMed ID: 28179131
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modifiable lifestyle risk factors for dry eye disease.
    Wang MTM; Muntz A; Mamidi B; Wolffsohn JS; Craig JP
    Cont Lens Anterior Eye; 2021 Dec; 44(6):101409. PubMed ID: 33485806
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TFOS DEWS II Introduction.
    Nelson JD; Craig JP; Akpek EK; Azar DT; Belmonte C; Bron AJ; Clayton JA; Dogru M; Dua HS; Foulks GN; Gomes JAP; Hammitt KM; Holopainen J; Jones L; Joo CK; Liu Z; Nichols JJ; Nichols KK; Novack GD; Sangwan V; Stapleton F; Tomlinson A; Tsubota K; Willcox MDP; Wolffsohn JS; Sullivan DA
    Ocul Surf; 2017 Jul; 15(3):269-275. PubMed ID: 28736334
    [No Abstract]   [Full Text] [Related]  

  • 70. Tear osmolarity as a biomarker for dry eye disease severity.
    Suzuki M; Massingale ML; Ye F; Godbold J; Elfassy T; Vallabhajosyula M; Asbell PA
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4557-61. PubMed ID: 20393114
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Automated Tear Film Surface Quality Breakup Time as a Novel Clinical Marker for Tear Hyperosmolarity in Dry Eye Disease.
    Downie LE
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7260-8. PubMed ID: 26544794
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Visual performance and the ocular surface in traumatic brain injury.
    Cockerham GC; Lemke S; Glynn-Milley C; Zumhagen L; Cockerham KP
    Ocul Surf; 2013 Jan; 11(1):25-34. PubMed ID: 23321357
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Categorization of the Aqueous Deficient Dry Eye by a Cut-Off Criterion of TMH Measured with Tearscope.
    Sabucedo-Villamarin B; Pena-Verdeal H; Garcia-Queiruga J; Giraldez MJ; Garcia-Resua C; Yebra-Pimentel E
    Life (Basel); 2022 Dec; 12(12):. PubMed ID: 36556372
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Comprehensive Study on Tear Meniscus Height Inter-Eye Differences in Aqueous Deficient Dry Eye Diagnosis.
    Pena-Verdeal H; Garcia-Queiruga J; Sabucedo-Villamarin B; Garcia-Resua C; Giraldez MJ; Yebra-Pimentel E
    J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. TFOS DEWS II Epidemiology Report.
    Stapleton F; Alves M; Bunya VY; Jalbert I; Lekhanont K; Malet F; Na KS; Schaumberg D; Uchino M; Vehof J; Viso E; Vitale S; Jones L
    Ocul Surf; 2017 Jul; 15(3):334-365. PubMed ID: 28736337
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Advances in understanding and managing dry eye disease.
    Lemp MA
    Am J Ophthalmol; 2008 Sep; 146(3):350-356. PubMed ID: 18599017
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome.
    Utine CA; Bıçakçıgil M; Yavuz S; Çiftçi F
    Curr Eye Res; 2011 Aug; 36(8):683-90. PubMed ID: 21780917
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
    Lee HS; Ji YS; Yoon KC
    Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
    [TBL] [Abstract][Full Text] [Related]  

  • 79. α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways.
    Ru Y; Huang Y; Liu H; Du J; Meng Z; Dou Z; Liu X; Wei RH; Zhang Y; Zhao S
    Sci Rep; 2015 Dec; 5():18619. PubMed ID: 26685899
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Autoimmune Disease-Related Dry Eye Diseases and Their Placement Under the Revised Classification Systems: An Update.
    Kılıççıoğlu A; Oncel D; Celebi ARC
    Cureus; 2023 Dec; 15(12):e50276. PubMed ID: 38196419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.